Earnings History Data for SELLAS Life Sciences Group, Inc. (SLS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group is a development-stage biopharmaceutical company. It focused on novel cancer immunotherapeutics for cancer indications. The company's product candidate, galinpepimut-S, is licensed from Memorial Sloan Kettering Cancer Center and targets the Wilms Tumor 1 protein, which is present in an array of tumor types. SELLAS Life Sciences Group Inc., formerly known as Galena Biopharma Inc., is based in NEW YORK, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-11-2024 | AH | SLS | SELLAS Life Sciences Group, Inc. | 86.85 | -0.10 | 0.00 | -0.33 | SELLAS Life Sciences GAAP EPS of -$0.10 beats by $0.03 [11/13/2024 5:49 PM] |
1.28 | 0.01 (0.79%) |
1.28 | 0.01 (0.79%) |
0.50 - 1.72 | 1,034,933 | 740,000 | 13,976 | ||
| 13-08-2024 | AH | SLS | SELLAS Life Sciences Group, Inc. | 68.15 | -0.13 | 0.00 | -0.31 | SELLAS Life Sciences GAAP EPS of -$0.13 beats by $0.04 [8/13/2024 4:47 PM] |
1.20 | 0.01 (0.84%) |
0.0 | 0.0 (0.00%) |
0.50 - 1.90 | 232,498 | 790,000 | 0 | ||
|
|
||||||||||||||||||
| 13-05-2021 | AH | 4:30 PM ET (May 13) |
SLS | SELLAS Life Sciences Group, Inc. | 123.69 | -0.16 | 0.00 | -0.66 | SELLAS Life Sciences EPS beats by $0.02 [5/13/2021 5:06 PM] |
8.15 | 0.54 (7.10%) |
8.40 | 0.79 (10.38%) |
1.76 - 19.38 | 298,220 | 190,000 | 131 | |